A European consortium backed by American cash is set to invest millions of dollars in a new operation in Portugal designed to supply the booming German medical cannabis market.
And cannabis financial market analysts are calling out Portugal as a prime location for those companies looking to take advantage of the rapidly growing European market. Health Europe reports that Cannexpor Pharma has secured permission from the Portuguese authorities for new indoor and outdoor cannabis growing facilities in the region of Coimbra, about 100 miles north of the capital Lisbon.
It says the facility will meet strict growing standards – GACP and GMP standards – and has secured the licence from Infarmed, the Portuguese licensing authority.
Read the full article at cbdtesters.co